House Passes 21st Century Cures Act, Companion Bill in Works in Senate
The House of Representatives on July 10 approved the 21st Century Cures Act by a vote of 344 to 77, moving focus to the Senate where efforts have begun to develop comparable legislation.
Sen. Lamar Alexander (R-Tenn.), chairman of the Senate HELP Committee, has said his committee is crafting legislation. “The HELP Committee is working on a bipartisan basis on this initiative and currently has five working groups meeting on a variety of FDA and NIH issues relating to drug and device innovation, from research to approval,” spokeswoman Margaret Atkinson tells CTA.
Peter Pitts, president of the Center for Medicine in the Public Interest, says the Senate could pass legislation by the fourth quarter of this year.
The massive overhaul bill would encourage broader use of observational studies, patient registries and actual therapeutic use to support approvals of new drugs and enhance postmarket surveillance, allow for greater use of innovative statistical methods in clinical trial designs and provide an extra six months of marketing exclusivity when drugmakers adapt existing products to treat rare diseases — beyond the seven years of exclusivity drugs get when granted orphan product status.
To speed access to novel therapies, drugmakers would be guaranteed FDA approval if investigational products met intermediate endpoints in an agreed-to development plan. The bill also directs the FDA to issue guidance on acquiring clinical evidence on different categories of drugs outside randomized clinical trials (CTA, June).
The Congressional Budget Office estimates that provisions in the bill, if implemented by the FDA, would cost $270 million from 2016 to 2020, according to a report issued June 23. Key provisions affecting research and development include:
The CBO report can be read here www.fdanews.com/06-24-15-cboreport.pdf.
Subscribe to Clinical Trials Advisor NOW and save $200 off the regular one-year price of $645 — plus receive a FREE copy of our webinar, Mastering Social Media for Clinical Trial Recruitment – a $347 value!
LINKS TO KEY DOCUMENTS — Need to read regulatory references, guidances, enforcement actions, and other documents? Simply click on the source documents in your electronic issue.
ONLINE ACCESS — Consider our newsletter archive your personal library! Search your current issue — and hundreds of past issues — by keyword and relevancy.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing